- Home
- Applications
- biomarkers
Refine by
Biomarkers Product Applications
28 applications found
Aidar Research offers CROs a cutting-edge approach by making decentralized and hybrid trials achievable and increasingly accessible to collect unique digital biomarkers, and to measure drug effectiveness, dosage variances, adverse reactions, and distinctive changes at the individual level thereby driving better outcomes, enhancing user engagement and fostering ...
ByAidar Health based in Baltimore, MARYLAND (USA)
Measuring mRNA transcript abundance with RNASeq methods offers clinical researchers a powerful platform to examine changes in the expression levels of multiple biomarkers. The power of targeted RNASeq lies in its ability to count the number of reads of a given transcript in a sample as a surrogate for expression level, much like a digital PCR system but able to measure 100s of biomarkers simultaneously. A challenge to widespread adoption of RNASeq transcript abundance measurement for clinical studies and ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)
Combine high sensitivity biomarker testing with traditional blood gas and ...
ByProxim Diagnostics Corp. based in Santa Clara, CALIFORNIA (USA)
Providing physicians with innovative and meaningful assays for the earlier detection of clinically significantly prostate ...
ByMDxHealth based in Irvine, CALIFORNIA (USA)
By using our platform, we provide great opportunities for integrating metagenomic analysis into translational parts of pharmaceutical development. Our experience in metagenomic evaluation of large patient cohorts provides know-how and understanding regarding microbiome related conditions and can be applied for target evaluation, and for biomarker identification and development of subsequent patient stratification tools. The MetaboGen network contains clinicians specialized in various diseases, providing access to ...
ByMetabogen AB based in Stockholm, SWEDEN
When it comes to brain health, you and your loved ones deserve as much clarity and accuracy as possible. That’s why Qynapse is dedicated to providing you and your physician with an objective view of your brain health. ...
ByQynapse based in Paris, FRANCE
Sepsis is one of the leading causes of death worldwide. It is a life-threatening condition caused by a dysregulated host response to infection, which can progress to multiple organ dysfunction, septic shock and even death 1. Every hour counts in sepsis. It’s a medical emergency that requires immediate diagnosis because any delay in treatment can dramatically reduce the chances of survival 2. ...
ByAbionic SA based in Epalinges, SWITZERLAND
Accelerate research with real-world data in cardiology across the industry. Join our forces to accelerate research in cardiology care, facilitate treatment improvement and optimize diagnosis and prediction of cardiovascular diseases. Together, we can provide healthcare professionals with decision support tools to improve healthcare outcomes for their ...
ByImplicity based in Paris, FRANCE
Colorectal cancer (CRC) is the third most common cancer all over the world. About 1.8 million new CRC cases were diagnosed globally in 2018, mostly in developed countries. The incidence of colorectal cancer is increasing in line with the ageing population. Early detection is key to successful treatment of the disease and related cost management. An efficient screening strategy is essential to detect the disease early, when it often does not produce symptoms. The currently available faecal occult blood test (FOBT) ...
ByDiagNodus Ltd. based in Cambridge, UNITED KINGDOM
Single cell RNA-Seq is revolutionizing the study of complex tissues and diseases. The powerful and easy-to-use tools in Partek® Flow® empower researchers to analyze their own single cell RNA-Seq ...
ByPartek Incorporated based in Chesterfield, MISSOURI (USA)
Microbiotica is using best-in-class clinical data and sample sets coupled with its unrivalled microbiome profiling capability to progress best-in-class therapeutics and biomarkers. Microbiotica has programs in IBD, Immuno-oncology and Gut Epithelial Barrier Repair developing medicines and biomarkers based on microbiota. These programs start with deep metagenomic and culture-based analysis of patient samples and involve advanced bioinformatics and machine learning, to identify highly significant bacterial ...
ByMicrobiotica Limited based in Little Chesterford, UNITED KINGDOM
Gene expression is the most fundamental level at which the genotype gives rise to a phenotype. Whether you have RNA-Seq, qPCR or microarray data, Partek provides easy-to-use tools that guide you through the analysis process from start to finish within a point-and-click interface. With over 8,000 citations, see why our gene expression analysis tools are the most trusted in the genomics ...
ByPartek Incorporated based in Chesterfield, MISSOURI (USA)
In modern healthcare, microscopic images, X-rays, CT, PET and MRI scans generate a lot of data which provides critical indicators for patient care and research. AI can help specialists manage this data. Robovision can provide or develop powerful tools to enhance the detection, classification, and quantification of lesions or ...
ByRobovision BV based in Ghent, BELGIUM
Tumor markers found in blood, urine and body tissues can be used in diagnosing and treating cancer. Each tumor marker is indicative of a particular disease and thus can be used for the screening, monitoring and diagnosis of specific tumor types. In addition to being used in prognosis, these molecular markers help to predict the response, resistance and toxicity to therapy. For example, BCR-ABL gene sequence detection is used to diagnose chronic myelogenous leukemia and acute lymphatic ...
ByAurora Biomed Inc. based in Vancouver, BRITISH COLUMBIA (CANADA)
Discover autoantigens in autoimmune diseases, delineate new candidate biomarkers. Autoantibodies are present in the blood of all healthy individuals. However, when directed at high levels against protein targets in specific tissues, autoantibodies can be a major cause of autoimmune diseases. They are also important biomarkers for diagnosis of these conditions. ...
ByCambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM
You need a complete answer to provide the best ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Whole genome, exome, or targeted panel DNA sequencing (DNA-Seq) studies can identify genetic variants that contribute to disease and phenotypes. Partek offers powerful and easy-to-use tools for processing and analyzing your DNA sequencing data. With the latest databases and bioinformatics tools available in a point-and-click interface, variant analysis is simple. ...
ByPartek Incorporated based in Chesterfield, MISSOURI (USA)
An electrical stimulation, i.e., action potential initiates cardiac contraction. Intracellular Ca2+-transient couples action potential and cardiac contraction. Cardiac contraction is also coupled to mitochondria that replenish energy (i.e., ATP) and recycle metabolites (ADP and Pi). InvivoSciences analyzes all those parameters to determine drug-induced or genetically driven changes in ECE ...
ByInvivoSciences, Inc. (IVS) based in Madison, WISCONSIN (USA)
Laser Force Cytology (LFC) and Radiance label-free approach to cell therapy research and biomanufacturing has significant value in expediting the process, decreasing costs, and ensuring therapy effectiveness and quality. Radiance enhances the highly complex biomanufacturing process for cell therapies by providing new insights to cell therapy research and process development. Current process development assays are fraught with difficult and time-consuming steps requiring highly skilled scientists and bioengineers ...
ByLumaCyte, Inc. based in Charlottesville, VIRGINIA (USA)
Kirkstall’s Quasi Vivo® system aims to establish and optimise a human in vitro 3D Blood Brain Barrier (BBB) in an effort to identify important mechanistic pathways for successful biomarker analysis, drug delivery and toxicity ...
ByKirkstall Ltd. based in York, UNITED KINGDOM